Your browser is no longer supported. Please, upgrade your browser.
EVFM Evofem Biosciences, Inc. weekly Stock Chart
Evofem Biosciences, Inc.
Index- P/E- EPS (ttm)-1.86 Insider Own2.00% Shs Outstand81.28M Perf Week-4.69%
Market Cap245.34M Forward P/E- EPS next Y-1.19 Insider Trans-91.58% Shs Float80.00M Perf Month-0.97%
Income-98.30M PEG- EPS next Q-0.51 Inst Own37.40% Short Float4.30% Perf Quarter-40.08%
Sales- P/S- EPS this Y65.40% Inst Trans-18.81% Short Ratio0.87 Perf Half Y-38.38%
Book/sh1.19 P/B2.56 EPS next Y42.80% ROA-180.40% Target Price- Perf Year-39.60%
Cash/sh1.54 P/C1.98 EPS next 5Y- ROE-359.90% 52W Range2.73 - 7.50 Perf YTD-50.57%
Dividend- P/FCF- EPS past 5Y42.70% ROI- 52W High-59.33% Beta0.24
Dividend %- Quick Ratio2.00 Sales past 5Y- Gross Margin- 52W Low11.72% ATR0.18
Employees53 Current Ratio2.10 Sales Q/Q- Oper. Margin- RSI (14)53.28 Volatility5.74% 5.21%
OptionableYes Debt/Eq0.65 EPS Q/Q5.40% Profit Margin- Rel Volume0.90 Prev Close2.93
ShortableYes LT Debt/Eq0.00 EarningsAug 04 BMO Payout- Avg Volume3.97M Price3.05
Recom1.70 SMA203.25% SMA50-2.66% SMA200-37.39% Volume3,558,597 Change4.10%
Jun-08-20Initiated Piper Sandler Overweight $11
Oct-16-19Resumed Cantor Fitzgerald Overweight $9
Aug-04-20 09:31PM  
Aug-03-20 08:30AM  
Jul-23-20 08:30AM  
Jul-21-20 03:55AM  
Jul-20-20 10:37AM  
Jul-15-20 08:30AM  
Jul-01-20 08:01AM  
Jun-29-20 09:33AM  
Jun-26-20 08:44AM  
Jun-12-20 08:08AM  
Jun-03-20 12:31PM  
Jun-02-20 11:03PM  
May-31-20 05:15PM  
May-28-20 06:30AM  
May-27-20 10:56AM  
May-26-20 10:32AM  
May-22-20 04:37PM  
May-21-20 04:05PM  
May-18-20 04:05PM  
May-13-20 08:00AM  
May-08-20 09:00AM  
May-07-20 07:30AM  
May-06-20 08:00AM  
May-01-20 05:21PM  
Apr-28-20 08:00AM  
Apr-24-20 08:30AM  
Apr-19-20 07:02AM  
Apr-10-20 04:05PM  
Mar-30-20 05:14PM  
Mar-27-20 08:30AM  
Mar-25-20 05:00PM  
Mar-24-20 04:00PM  
Mar-19-20 08:15AM  
Mar-12-20 09:00AM  
Mar-09-20 11:53AM  
Feb-26-20 08:30AM  
Feb-16-20 08:25AM  
Dec-22-19 05:32PM  
Dec-18-19 07:30AM  
Dec-03-19 09:00AM  
Dec-02-19 08:07AM  
Nov-24-19 04:19PM  
Nov-14-19 08:00AM  
Nov-13-19 04:05PM  
Nov-08-19 08:30PM  
Nov-07-19 11:26AM  
Nov-06-19 04:05PM  
Oct-24-19 09:00AM  
Sep-25-19 09:00AM  
Sep-11-19 01:31PM  
Aug-26-19 06:00AM  
Aug-22-19 09:30AM  
Aug-08-19 11:23AM  
Aug-05-19 04:10PM  
Jul-30-19 09:00AM  
Jul-01-19 09:31AM  
Jun-10-19 04:01PM  
May-30-19 11:02AM  
May-14-19 09:00AM  
May-10-19 10:51AM  
May-09-19 07:24PM  
May-07-19 06:00AM  
Apr-30-19 09:00AM  
Apr-23-19 08:11AM  
Apr-16-19 08:30AM  
Apr-11-19 10:25AM  
Apr-03-19 09:00AM  
Mar-12-19 09:00AM  
Mar-03-19 11:00PM  
Mar-01-19 06:00AM  
Feb-19-19 09:00AM  
Jan-07-19 07:20AM  
Jan-03-19 08:00AM  
Dec-20-18 10:13AM  
Dec-19-18 09:17AM  
Dec-18-18 02:01PM  
Dec-17-18 01:30PM  
Nov-15-18 06:50AM  
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, a vaginal pH regulator for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rarick Lisa DaleDirectorJun 17Buy2.995,25015,6985,250Jun 18 04:29 PM
Hall William WalmsleyDirectorJun 15Buy2.855,00014,2505,000Jun 17 08:38 PM
File Justin J.Chief Financial OfficerJun 12Buy3.148,50026,690250,408Jun 15 04:16 PM
Kamdar Kim P.DirectorJun 12Buy2.945,00014,7009,287Jun 16 04:35 PM
Invesco Ltd.10% OwnerJun 05Buy3.50857,1433,000,00113,226,532Jun 09 06:49 AM
Link Fund Solutions Ltd10% OwnerJun 04Sale0.239,138,5042,101,8560Jul 17 11:11 AM
ACACIA RESEARCH CORP10% OwnerJun 04Sale3.219,138,50429,325,4591,000Jun 09 09:08 PM
Invesco Ltd.10% OwnerMay 26Sale5.7973,879427,77212,369,389Jun 09 06:49 AM
Invesco Ltd.10% OwnerMay 15Sale5.043,21116,18312,443,268Jun 09 06:49 AM
Culwell KellyChief Medical OfficerMay 01Sale4.751,0004,750194,226May 01 08:12 PM
Culwell KellyChief Medical OfficerApr 30Sale4.661,0004,660195,226May 01 08:12 PM
Lynch Thomas GDirectorMar 31Option Exercise0.0037,5000325,000Apr 01 04:11 PM
Barrans RussellChief Commercial OfficerFeb 19Sale6.5014,95797,221332,240Feb 21 02:10 PM
Culwell KellyChief Medical OfficerFeb 19Sale7.001,0007,000196,226Feb 21 02:10 PM
Barrans RussellChief Commercial OfficerJan 16Sale6.501,57810,257196,298Jan 21 01:13 PM
PELLETIER SAUNDRA LChief Executive OfficerJan 13Sale6.003,29519,770362,289Jan 15 04:22 PM
File Justin J.Chief Financial OfficerJan 13Sale6.001,6489,888177,251Jan 15 04:22 PM
File Justin J.Chief Financial OfficerJan 02Sale6.053,35220,280178,899Jan 06 03:07 PM
PELLETIER SAUNDRA LChief Executive OfficerJan 02Sale6.056,70540,565365,584Jan 06 03:08 PM
Lynch Thomas GDirectorDec 31Option Exercise0.0037,5000287,500Dec 31 08:48 PM
Culwell KellyChief Medical OfficerDec 02Sale7.351,0007,35043,538Dec 04 05:34 PM
PELLETIER SAUNDRA LChief Executive OfficerDec 02Sale7.3020,000146,000372,289Dec 04 05:33 PM
File Justin J.Chief Financial OfficerDec 02Sale7.1610,00071,600182,251Dec 04 05:33 PM
PELLETIER SAUNDRA LChief Executive OfficerNov 21Sale6.0110,00060,100414,676Nov 21 08:18 PM
File Justin J.Chief Financial OfficerNov 21Sale6.004,90029,400202,353Nov 21 08:18 PM
File Justin J.Chief Financial OfficerNov 20Sale6.00100600207,253Nov 21 08:18 PM